查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年製药隔离器市场预测：按类型、系统类型、压力、配置、配销通路、应用、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1383483

2030 年製药隔离器市场预测：按类型、系统类型、压力、配置、配销通路、应用、最终用户和地区进行的全球分析

Pharmaceutical Isolator Market Forecasts to 2030 - Global Analysis By Type, System Type, Pressure, Configuration, Distribution Channel, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球药物隔离器市场规模为 124.5 亿美元，预计 2030 年将达到 248.2 亿美元，预测期内年复合成长率为 10.36%。

药物隔离器用作屏障系统以防止污染。药物隔离器用于多种行业，包括微生物测试、细胞治疗加工、先进药物製造 (ATMP) 以及无菌注射剂计量、包装和分销。

根据美国药物研究和工业2021 年 9 月更新的资料，自 2000 年以来，PhRMA 成员公司已花费超过 1.1 兆美元寻找新的治疗方法和治疗方法。光是 2021 年我们就投资了 1,023 亿美元。

对药理学无菌操作的需求不断增加

人们越来越认识到清洁度在药品製造中发挥的关键作用，这推动了对无菌製剂製程的需求。製药公司努力提供最好的药物，使隔离器成为必不可少的设备。此外，我们透过最先进的密封和空气过滤系统仔细监控环境，确保我们的药品保持纯净和完好无损。

预算限制和前期投资

药物隔离器具有许多优点，包括法规遵循和污染控制，但其安装需要初期成本。然而，一些製药公司可能会发现很难为隔离系统的设计、安装和检验提供资金，特别是当它们规模较小或资金有限时。儘管隔离器能带来长期好处，但这种财务障碍可能会阻碍普及。

隔离器技术开发

随着隔离器技术的不断进步，製药公司拥有许多机会。有助于隔离器解决方案开发的创新包括更好的密封系统、改进的材料设计和更易于使用的介面。此外，投资于研发的隔离器技术领域的公司可以透过解决现有问题并提供满足不断变化的市场需求的尖端解决方案来受益于竞争优势。

替代遏制技术的兴起

药物隔离器在市场上的主导地位受到密封技术动态环境中替代解决方案的出现的威胁。根据应用的不同，先进的屏障技术、机器人系统或封闭系统处理替代方案可能是吸引人们对传统隔离器解决方案的关注和资金的可行选择。此外，隔离器製造商必须不断创新并突显其产品的独特价值提案，以减轻此威胁。

COVID-19 的影响：

药物隔离器市场受到了 COVID-19大流行的各种影响。由于大流行，对药物开发和医疗保健的日益关注推动了对药物隔离器的需求，但也受到劳动力短缺、全球供应链中断和不确定的经济状况的阻碍。此外，疫情凸显了灵活敏捷的製造流程的重要性，促使公司重新评估和改进其遏制计划。这可能会刺激大流行后药物隔离器市场的创新。

预计落地式细分市场在预测期内将是最大的

由于其宽敞的工作空间和针对不同製造流程的弹性，落地式细分市场在药物隔离器市场中占据最大份额。落地式隔离器为复杂任务提供了更多空间，可容纳更大的设备并支援符合人体工学的工作流程。此外，由于其高度通用性，它适用于广泛的应用，例如高药理活性药物的生产和无菌加工。复杂的控制系统、材料通过系统和整合式手套口只是这些隔离器经常采用的一些先进功能。

合约研究组织部门预计在预测期内复合年复合成长率最高。

合约市场研究组织（CRO）是复合年复合成长率最高的细分市场。 CRO 对于生物技术和製药行业至关重要，因为它们为研究和开发提供专业服务。外包药物开发和临床试验的趋势正在推动对先进实验室设备的需求，包括尖端的诊断工具和设备。此外，CRO 利用学术机构、研究中心和诊断实验室进行广泛的研究，加速最尖端科技的采用。

占比最大的地区：

由于其强大的医疗保健系统、高研发支出和严格的法规要求，北美目前占据药物隔离器市场的最大份额。该地区运营的大量受託研究机构以及製药和生物技术公司对隔离系统的需求产生了重大影响。此外，我们积极主动地实施最尖端科技，以及我们对维持产品品质和安全最高标准的承诺，正在推动药物隔离器在北美的普及。

复合年复合成长率最高的地区：

由于生物技术和製药行业的市场开拓活跃，亚太地区的市场年复合成长率最高。该地区正在增加对医疗基础设施的投资、更加重视研发以及药物开发活动的激增。此外，由于患者人数众多、医疗成本上升和支持性法律规范多种因素，药物隔离器市场正在成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球药物隔离器市场：按类型

  • 无菌隔离器
  • 安全壳隔离装置
  • 生物隔离器
  • 采样和计量隔离器
  • 用于生产活性药物原料药(API) 的隔离器
  • 放射性药物隔离器
  • 液体分配隔离器
  • 生产隔离器
  • 其他类型

第6章全球药物隔离器市场：依系统类型

  • 封闭系统
  • 开放系统

第7章全球药物隔离器市场：压力

  • 正压
  • 负压

第8章全球药物隔离器市场：依构成

  • 放置楼层
  • 模组化的
  • 智慧型手机
  • 袖珍的
  • 桌上
  • 便携的
  • 其他配置

第9章全球药物隔离器市场：依配销通路

  • 直接竞标
  • 零售
  • 第三方经销商

第10章全球药物隔离器市场：依应用分类

  • 无菌测试
  • 取样/称重/交付
  • 医疗设备製造
  • 其他用途

第11章全球药物隔离器市场：依最终用户分类

  • 医院
  • 诊断实验室
  • 学术研究所
  • 製药和生物技术公司
  • 合约研究组织
  • 其他最终用户

第12章全球药物隔离器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第13章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第14章公司简介

  • Getinge AB
  • Fedegari Autoclavi SpA
  • Azbil Corporation
  • Schematic Engineering Industries
  • Germfree Laboratories, Inc.
  • Chiyoda Corporation
  • Hosokawa Micron BV
  • Bioquell Inc.
  • NuAire Inc
  • Hecht Technologie Gmbh
  • Comecer SPA
  • Skan AG
  • M. Braun Inertgas-Systeme Gmbh
  • Tema Sinergie SPA
  • Chamunda Pharma Machinery Pvt. Ltd
  • Isotech Design
Product Code: SMRC24331

According to Stratistics MRC, the Global Pharmaceutical Isolator Market is accounted for $12.45 billion in 2023 and is expected to reach $24.82 billion by 2030 growing at a CAGR of 10.36% during the forecast period. Pharmaceutical isolators are employed as a barrier system that prevents contamination. Pharmaceutical isolators are used in a variety of industries, including microbiological testing, cell therapy processing, advanced pharmaceutical manufacturing (ATMP) and the weighing, packaging, and distribution of sterile injectable products.

According to the Pharmaceutical Research and Manufacturers of America data updates from September 2021, since 2000, PhRMA member companies have invested more than USD 1.1 Trillion in the search for new treatments and cures, including USD 102.3 Billion in 2021 alone.

Market Dynamics:

Driver:

Growing requirement for pharmacological sterile procedures

The increasing recognition of the vital role cleanliness plays in the production of pharmaceuticals is driving the demand for sterile pharmaceutical processes. Isolators become essential instruments as pharmaceutical companies work to provide the best possible drugs. Moreover, pharmaceutical products are kept pure and undamaged thanks to these carefully monitored settings that are outfitted with cutting-edge containment and air filtration systems.

Restraint:

Budgetary restrictions and upfront investment

Pharmaceutical isolators have many advantages, such as regulatory compliance and contamination control, but their installation is expensive up front. However, some pharmaceutical companies may find it difficult to afford the costs involved in designing, installing, and validating isolator systems, particularly smaller ones or those with more restricted funding. Despite the long-term benefits that isolators offer, this financial barrier may prevent widespread adoption.

Opportunity:

Technological developments in isolators

Pharmaceutical companies have a lot of potential thanks to ongoing advancements in isolator technology. Innovations that contribute to the development of isolator solutions include better containment systems, improved material designs, and more user-friendly interfaces. Moreover, businesses in the isolator technology sector that make research and development investments stand to benefit from a competitive advantage by providing cutting-edge solutions that solve existing issues and fit the changing demands of the market.

Threat:

Rising alternative technologies for containment

The dominant position of pharmaceutical isolators in the market is under threat from the emergence of alternative solutions in the dynamic landscape of containment technologies. For some applications, advanced barrier technologies, robotic systems, or alternatives to closed-system processing may be viable options that draw attention and funding away from conventional isolator solutions. Additionally, manufacturers of isolators must constantly innovate and highlight the distinctive value proposition of their goods in order to lessen this threat.

COVID-19 Impact:

The pharmaceutical isolator market has been impacted by the COVID-19 pandemic in many ways. The demand for pharmaceutical isolators has been fueled by the pandemic's increased focus on drug development and healthcare, but there have been obstacles due to workforce shortages, global supply chain disruptions, and uncertain economic conditions. Furthermore, the pandemic has highlighted the significance of flexible and agile manufacturing processes, leading businesses to reevaluate and improve their containment plans. This could spur innovation in the pharmaceutical isolator market in the aftermath of the pandemic.

The Floor standing segment is expected to be the largest during the forecast period

Due to its prominence in offering ample workspace and flexibility for a variety of manufacturing processes, the floor-standing segment holds the largest share of the pharmaceutical isolator market. With room for larger equipment and the ability to support ergonomic workflows, floor-standing isolators provide large spaces for intricate operations. Moreover, these are appropriate for a wide range of applications, including high-potency drug manufacturing and aseptic processing, due to their versatility. Complex control systems, material pass-through systems, and integrated glove ports are just a few examples of the advanced features that these isolators frequently incorporate.

The Contract Research Organizations segment is expected to have the highest CAGR during the forecast period

Contract Research Organizations (CROs) are the market segment with the highest CAGR. CROs are essential to the biotechnology and pharmaceutical industries because they offer specialized services for research and development. The need for sophisticated laboratory equipment, including cutting-edge diagnostic tools and instruments, has increased due to the trend of outsourcing drug development and clinical trials. Furthermore, CROs use academic institutions, research centers, and diagnostic labs to carry out extensive studies that promote the uptake of cutting-edge technologies.

Region with largest share:

Due to its strong healthcare system, large R&D expenditures, and strict regulatory requirements, North America presently commands the largest share of the market for pharmaceutical isolators. The numerous contract research organizations and the pharmaceutical and biotechnology companies that operate in the area have a significant impact on the demand for isolator systems. Moreover, a proactive approach to implementing state-of-the-art technologies and a strong focus on upholding the highest standards of product quality and safety add to the prevalence of pharmaceutical isolators in North America.

Region with highest CAGR:

The Asia-Pacific-Pacific has the highest CAGR in the market, driven by dynamic developments in the biotechnology and pharmaceutical industries. Increased investments in healthcare infrastructure, a growing focus on research and development, and a surge in drug development activities are all occurring in the region. Additionally, the market for pharmaceutical isolators is growing due to a number of factors, including a large patient population, rising healthcare costs, and a supportive regulatory framework.

Key players in the market

Some of the key players in Pharmaceutical Isolator market include: Getinge AB, Fedegari Autoclavi S.p.A, Azbil Corporation, Schematic Engineering Industries, Germfree Laboratories, Inc., Chiyoda Corporation, Hosokawa Micron B.V, Bioquell Inc., NuAire Inc, Hecht Technologie Gmbh, Comecer S.P.A, Skan AG, M. Braun Inertgas-Systeme Gmbh, Tema Sinergie S.P.A, Chamunda Pharma Machinery Pvt. Ltd and Isotech Design.

Key Developments:

In October 2023, Azbil Corporation has announced an investment agreement with Forest Energy Inc., headquartered in Tokyo. To support the realization of a sustainable society powered by renewable energy, Azbil is underwriting Forest Energy's third-party allocation of Renewable Energynew shares.

In October 2023, Germfree Laboratories and Title21 Health Solutions unveil a groundbreaking mobile manufacturing platform seamlessly integrated with an advanced manufacturing operating system, set to redefine decentralized point-of-care (POC) cell and gene therapy production. This partnership focuses on decentralized manufacturing, an innovative approach to traditional centralized models, aiming to overcome bottlenecks and streamline access to therapy delivery.

In May 2023, Getinge announces an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment, says Eric Honroth, President Life Science at Getinge.

Types Covered:

  • Aseptic Isolators
  • Containment Isolators
  • Bio Isolators
  • Sampling And Weighing Isolators
  • Active Pharmaceutical Ingredient (API) Manufacturing Isolators
  • Radiopharmaceutical Isolators
  • Fluid Dispensing Isolators
  • Production Isolators
  • Other Types

System Types Covered:

  • Closed System
  • Open System

Pressures Covered:

  • Positive Pressure
  • Negative Pressure

Configurations Covered:

  • Floor Standing
  • Modular
  • Mobile
  • Compact
  • Table Top
  • Portable
  • Other Configuartions

Distribution Channels Covered:

  • Direct Tender
  • Retail Sales
  • Third Party Distributors

Applications Covered:

  • Sterility Testing
  • Sampling/ Weighing/ Distribution
  • Medical Device Manufacturing
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Isolator Market, By Type

  • 5.1 Introduction
  • 5.2 Aseptic Isolators
  • 5.3 Containment Isolators
  • 5.4 Bio Isolators
  • 5.5 Sampling And Weighing Isolators
  • 5.6 Active Pharmaceutical Ingredient (API) Manufacturing Isolators
  • 5.7 Radiopharmaceutical Isolators
  • 5.8 Fluid Dispensing Isolators
  • 5.9 Production Isolators
  • 5.10 Other Types

6 Global Pharmaceutical Isolator Market, By System Type

  • 6.1 Introduction
  • 6.2 Closed System
  • 6.3 Open System

7 Global Pharmaceutical Isolator Market, By Pressure

  • 7.1 Introduction
  • 7.2 Positive Pressure
  • 7.3 Negative Pressure

8 Global Pharmaceutical Isolator Market, By Configuration

  • 8.1 Introduction
  • 8.2 Floor Standing
  • 8.3 Modular
  • 8.4 Mobile
  • 8.5 Compact
  • 8.6 Table Top
  • 8.7 Portable
  • 8.8 Other Configuartions

9 Global Pharmaceutical Isolator Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct Tender
  • 9.3 Retail Sales
  • 9.4 Third Party Distributors

10 Global Pharmaceutical Isolator Market, By Application

  • 10.1 Introduction
  • 10.2 Sterility Testing
  • 10.3 Sampling/ Weighing/ Distribution
  • 10.4 Medical Device Manufacturing
  • 10.5 Other Applications

11 Global Pharmaceutical Isolator Market, By End User

  • 11.1 Introduction
  • 11.2 Hospitals
  • 11.3 Diagnostic Laboratories
  • 11.4 Academic and Research Institutes
  • 11.5 Pharmaceutical and Biotechnology Companies
  • 11.6 Contract Research Organizations
  • 11.7 Other End Users

12 Global Pharmaceutical Isolator Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Getinge AB
  • 14.2 Fedegari Autoclavi S.p.A
  • 14.3 Azbil Corporation
  • 14.4 Schematic Engineering Industries
  • 14.5 Germfree Laboratories, Inc.
  • 14.6 Chiyoda Corporation
  • 14.7 Hosokawa Micron B.V
  • 14.8 Bioquell Inc.
  • 14.9 NuAire Inc
  • 14.10 Hecht Technologie Gmbh
  • 14.11 Comecer S.P.A
  • 14.12 Skan AG
  • 14.13 M. Braun Inertgas-Systeme Gmbh
  • 14.14 Tema Sinergie S.P.A
  • 14.15 Chamunda Pharma Machinery Pvt. Ltd
  • 14.16 Isotech Design

List of Tables

  • Table 1 Global Pharmaceutical Isolator Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Isolator Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Isolator Market Outlook, By Aseptic Isolators (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Isolator Market Outlook, By Containment Isolators (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Isolator Market Outlook, By Bio Isolators (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Isolator Market Outlook, By Sampling And Weighing Isolators (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Isolator Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing Isolators (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Isolator Market Outlook, By Radiopharmaceutical Isolators (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Isolator Market Outlook, By Fluid Dispensing Isolators (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Isolator Market Outlook, By Production Isolators (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Isolator Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Isolator Market Outlook, By System Type (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Isolator Market Outlook, By Closed System (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Isolator Market Outlook, By Open System (2021-2030) ($MN)
  • Table 15 Global Pharmaceutical Isolator Market Outlook, By Pressure (2021-2030) ($MN)
  • Table 16 Global Pharmaceutical Isolator Market Outlook, By Positive Pressure (2021-2030) ($MN)
  • Table 17 Global Pharmaceutical Isolator Market Outlook, By Negative Pressure (2021-2030) ($MN)
  • Table 18 Global Pharmaceutical Isolator Market Outlook, By Configuration (2021-2030) ($MN)
  • Table 19 Global Pharmaceutical Isolator Market Outlook, By Floor Standing (2021-2030) ($MN)
  • Table 20 Global Pharmaceutical Isolator Market Outlook, By Modular (2021-2030) ($MN)
  • Table 21 Global Pharmaceutical Isolator Market Outlook, By Mobile (2021-2030) ($MN)
  • Table 22 Global Pharmaceutical Isolator Market Outlook, By Compact (2021-2030) ($MN)
  • Table 23 Global Pharmaceutical Isolator Market Outlook, By Table Top (2021-2030) ($MN)
  • Table 24 Global Pharmaceutical Isolator Market Outlook, By Portable (2021-2030) ($MN)
  • Table 25 Global Pharmaceutical Isolator Market Outlook, By Other Configuartions (2021-2030) ($MN)
  • Table 26 Global Pharmaceutical Isolator Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 27 Global Pharmaceutical Isolator Market Outlook, By Direct Tender (2021-2030) ($MN)
  • Table 28 Global Pharmaceutical Isolator Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 29 Global Pharmaceutical Isolator Market Outlook, By Third Party Distributors (2021-2030) ($MN)
  • Table 30 Global Pharmaceutical Isolator Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 Global Pharmaceutical Isolator Market Outlook, By Sterility Testing (2021-2030) ($MN)
  • Table 32 Global Pharmaceutical Isolator Market Outlook, By Sampling/ Weighing/ Distribution (2021-2030) ($MN)
  • Table 33 Global Pharmaceutical Isolator Market Outlook, By Medical Device Manufacturing (2021-2030) ($MN)
  • Table 34 Global Pharmaceutical Isolator Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 35 Global Pharmaceutical Isolator Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 Global Pharmaceutical Isolator Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 Global Pharmaceutical Isolator Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 38 Global Pharmaceutical Isolator Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 39 Global Pharmaceutical Isolator Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 40 Global Pharmaceutical Isolator Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 41 Global Pharmaceutical Isolator Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.